News Center
Blog
Looking Ahead to 2025: The Global Biopharmaceutical Industry
Release time:
2024-11-14
Looking at the historical timeline of the global biopharmaceutical industry development, many changes are occurring in 2025.
Looking at the historical axis of global biopharmaceutical industry development, many changes are happening in 2025. In terms of new drug development, weight loss drugs have entered the vast field of cardiovascular and metabolic diseases, becoming a hot topic after traditional specialty drugs such as oncology, immunology, and rare disease therapies. At the same time, the overall industrial environment is also changing - although the funding environment for investment and mergers and acquisitions seems to be recovering, the medical system that has not fully adapted to the logic of innovative drugs is difficult to support the return of innovative drugs. As a result, many countries' medical systems have embarked on the path of reform, and patient leadership is increasing. On the other hand, AI pharmaceuticals, which once confused Chinese investors, are playing an increasingly important role in global healthcare services, and relevant application regulations will also be introduced in 2025... We are in an environment full of uncertainty, and geopolitical frictions are still threatening the globalization trend of the biopharmaceutical industry, but the fundamentals of the biopharmaceutical industry may change by 2025.
Address: Zhigu Workshop, 2239 Longcheng Avenue, Zhonglou District, Changzhou City, Jiangsu Province
E-mail: info@anikare.com
E-mail: sales@anikare.com